Clinical Trials Directory

Trials / Completed

CompletedNCT04794634

Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Alzheimer disease is hard, long and expensive to diagnose. In order to help the clinician, a new biomarker in Alzheimer disease seems to be very useful. The retina, as a window of the brain, could offer a new way to diagnose this common disease. Indeed, a retinal atrophy could especially appear in Alzheimer disease. Besides, many aspects about retinal alteration, visual function and their link with the disease deserve to be more explored. So as to fill these gaps, a new study about retinal specificity in Alzheimer disease appears to be relevant.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOptical coherence tomography (OCT)to make a complete ophthalmological and neurological examination, an OCT to AD and to compare their results with LD and controls subjects
DIAGNOSTIC_TESTOptical coherence tomograpohy angiography (OCTA)to make a complete ophthalmological and neurological examination, an OCT and OCTA, to AD and to compare their results with LD and controls subjects

Timeline

Start date
2021-01-13
Primary completion
2023-06-23
Completion
2025-12-01
First posted
2021-03-12
Last updated
2025-12-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04794634. Inclusion in this directory is not an endorsement.